Navigation Links
BMP Sunstone Adopts Voluntary Executive Compensation Restrictions in 2008 and 2009
Date:1/12/2009

PLYMOUTH MEETING, Pa., Jan. 12 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company"), today announced that senior executives voluntarily elected certain compensation restrictions in the fiscal years 2008 and 2009. Senior executives rescinded any 2008 bonus payments, and elected to not increase executive salaries while also reducing stock option compensation for 2009. In addition, the Board of Directors voluntarily reduced their stock option compensation for 2009. After consideration of BMP Sunstone's many achievements during 2008 and management's commitment to the Company, this offer was approved by the Compensation Committee of the Board of Directors.

David Gao, Chief Executive Officer of BMP Sunstone, stated, "The year 2008 was a turning point for our Company as we achieved record top and bottom-line financial performance, completed transformative acquisitions with Sunstone and Rongheng, solidified our presence in China's top three pharmaceutical markets of Beijing, Shanghai and Guangzhou, diversified our product offering with exciting new product launches and product approvals, and strengthened our management team across the organization. Despite the Company's significant progress during 2008, the board and management team have decided to take these compensation restrictions in recognition of the current global economic environment. The success achieved in 2008 enables us to enter 2009 in a strong competitive position and to continue growing our business. We remain enthusiastic about the business prospects in China's rapidly growing healthcare sector."

About BMP Sunstone Corporation

BMP Sunstone Corporation is a specialty pharmaceutical company that is building a proprietary portfolio of branded pharmaceutical and healthcare products in China. Currently this portfolio includes eight products under exclusive multi-year licenses for China, primarily focused on women's health and pediatrics. The Company also owns Sunstone Pharmaceutical Co. Ltd., which manufactures leading pediatric and women's health products, including two of China's most recognized brands, "Hao Wawa" and "Confort," sold through approximately 50,000 pharmacies in China. The Company also provides pharmaceutical distribution services through its subsidiaries in Beijing and Shanghai, and through its affiliate, Guangzhou Pharmaceuticals Corp. The Company has its main office in Beijing, with a US office in Plymouth Meeting, PA. For more information, please visit http://www.bmpsunstone.com .


'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. BMP Sunstone Receives High Tech Status
2. BMP Sunstone to Present at the 20th Annual Piper Jaffray Health Care Conference
3. BMP Sunstone Acquires Runchang Capsule and Related LFHC Technology
4. BMP Sunstone to Host Follow-Up 3Q08 Conference Call Due to Technical Difficulties Encountered on Tuesdays Call
5. BMP Sunstone Reports Third Quarter 2008 Financial Results
6. BMP Sunstone Announces Participation in November Investor Conferences
7. BMP Sunstone Announces Participation in September Investor Conference
8. BMP Sunstone Receives Production License from the SFDA to Manufacture and Market Pediatric Multivitamin Granules in the PRC
9. BMP Sunstone Reports Second Quarter 2008 Financial Results
10. BMP Sunstone Corporation Appoints Zhiqiang Han to President and Chief Operating Officer
11. BMP Sunstone Receives Import Drug License (IDL) from SFDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... 2016 , ... Supplyframe, the Industry Network for electronics hardware ... . Located in Pasadena, Calif., the Design Lab’s mission is to bring together ... built and brought to market. , The Design Lab is Supplyframe’s physical representation ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the ... the Dow Jones Industrial Average edged 0.27% lower to finish ... 0.17%. Stock-Callers.com has initiated coverage on the following equities: Infinity ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... ). Learn more about these stocks by accessing their free ...
Breaking Biology Technology:
(Date:5/3/2016)... 3, 2016  Neurotechnology, a provider of high-precision ... Automated Biometric Identification System (ABIS) , a complete ... MegaMatcher ABIS can process multiple complex biometric transactions ... of fingerprint, face or iris biometrics. It leverages ... and MegaMatcher Accelerator , which have been ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
Breaking Biology News(10 mins):